Bridgebio Pharma, Inc. · NASDAQ:BBIO
Apuli Maricel had 4,714 Bridgebio Pharma, Inc. shares withheld for tax (Form 4)
Traded Aug 16, 2026 · Filed Aug 18, 2026
On Aug 16, 2026, Apuli Maricel (Chief Accounting Officer) had 4,714 Bridgebio Pharma, Inc. shares withheld for tax at US$79.86 for US$376K, leaving 122,687 shares. Filed Aug 18, 2026 (Form 4).
- Withheld for tax
- 4,714 shares
- Price
- US$79.86
- Value
- US$376K
- Holding after
- 122,687 shares
- Trading plan
- No
- Role
- Chief Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 16, 2026 | Common Stock | Shares withheld for tax | 4,714 | US$79.86 | 122,687 | Direct |
Source
Related
- Bridgebio Pharma, Inc.
- Apuli Maricel
- Bridgebio Pharma, Inc. shareholders
- Form 4 · Apuli Maricel · Aug 3, 2026
- Form 4 · Apuli Maricel · May 19, 2026
- Form 4 · Apuli Maricel · May 4, 2026
- Form 4 · Kumar Neil · Sep 21, 2026
- Form 4 · Kumar Neil · Aug 20, 2026
- Form 4 · Kumar Neil · Aug 18, 2026
- Form 4 · Trimarchi Thomas · Aug 18, 2026
- Schedule 13D/A · KKR Genetic Disorder L.P. · Aug 17, 2026